Smallpox vaccine - DynPort Vaccine Company
Alternative Names: CCSVLatest Information Update: 02 Oct 2021
At a glance
- Originator DynPort Vaccine Company LLC
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Smallpox
Most Recent Events
- 23 Aug 2004 DynPort Vaccine Company LLC has been acquired by Computer Sciences Corporation
- 04 Nov 2003 Data presented at the 41st Annual Meeting of the Infectious Diseases Society of America (IDSA-2003) have been added to the Viral Infections immunogenicity section
- 29 Sep 2003 Data presented at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2003) have been added to the adverse events and Viral Infections immunogenicity sections